Table 3.
BMSCs | MSCs | MBs | CSCs | EPCs | ESCs | iPSCs | |
---|---|---|---|---|---|---|---|
Origin | Bone marrow | Bone marrow, heart, lung, adipose tissue | Muscle | Heart | Bone marrow, peripheral blood | ICM of blastocysts | Diverse tissues |
Differentiated cells | |||||||
CMs | Controversial | Controversial | Controversial | Possible | Impossible | Possible | Possible |
Endothelial cells | Possible | Possible | No report | Possible | Possible | Possible | Possible |
SMCs | Possible | Possible | No report | Possible | Impossible | Possible | Possible |
Other cell types | Unknown | Possible | No report | Controversial | Impossible | Possible | Possible |
Immunogenicity | Unlikely if autologous | Unlikely if autologous | Unlikely if autologous | Unlikely if autologous | Unlikely if autologous | Exists | Unlikely if autologous |
Electrochemical coupling | No | Yes | No | Possible | – | Possible | Possible |
Paracrine effect | Exists | Exists | Exists | Exists | Exists | Exists | Exists |
In vitro expansion | Limited | Limited | Limited | Limited | Limited | Yes | Yes |
Clinical safety | Yes | Yes | Side effects reported | Yes | Yes | Teratoma formation, ethical concerns, arrhythmia | Teratoma formation, mutagenesis, arrhythmia |
BMSC bone marrow stem cell, MSC mesenchymal stem cell, MB mybolast, CSC cardiac stem cell, EPC endothelial progenitor cell, ESC embryonic stem cell, ICM inner cell mass, iPSC induced pluripotent stem cell, CM cardiomyocyte